Greenleaf Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-629	Closed	-$207K	–	802
2024 Q4	$207K	Buy	629 +26	+4%	+$8.82K	﹤0.01%	773
2024 Q3	$202K	Buy	+603	New	+$192K	﹤0.01%	801
2024 Q2	–	Sell	-682	Closed	-$236K	–	799
2024 Q1	$236K	Sell	682 -13	-2%	-$4.28K	﹤0.01%	692
2023 Q4	$224K	Buy	+695	New	+$218K	﹤0.01%	688
2023 Q3	–	Sell	-551	Closed	-$209K	–	748
2023 Q2	$209K	Buy	551 +40	+8%	+$16.3K	﹤0.01%	715
2023 Q1	$245K	Buy	+511	New	+$239K	﹤0.01%	667
2022 Q3	–	Sell	-421	Closed	-$208K	–	716
2022 Q2	$208K	Sell	421 -23	-5%	-$12K	﹤0.01%	666
2022 Q1	$250K	Sell	444 -18	-4%	-$10.9K	﹤0.01%	651
2021 Q4	$349K	Buy	462 +33	+8%	+$24.7K	﹤0.01%	549
2021 Q3	$320K	Buy	429 +18	+4%	+$13.5K	﹤0.01%	552
2021 Q2	$265K	Buy	411 +5	+1%	+$3.04K	﹤0.01%	619
2021 Q1	$232K	Buy	406 +20	+5%	+$11.8K	﹤0.01%	642
2020 Q4	$225K	Buy	+386	New	+$220K	﹤0.01%	565